Bioventus Inc. (BVS) Profit Margins
Over the twelve months to 2026-06-30, Bioventus Inc. (BVS) had gross margin 68.7%, operating margin 10.0%, net margin 9.4%, free cash flow margin 16.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BVSBioventus Inc.Follow BVS — free
—
Price chart with a free account
- Market cap
- 1.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | 70.3% | 64.6% | 64.1% | 67.7% | 68.3% | 68.7% | |
| Operating margin | 2.8% | -32.7% | -16.0% | -2.7% | 9.5% | 10.0% | |
| Net margin | 4.5% | -31.0% | -30.5% | -6.3% | 4.0% | 9.4% | |
| FCF margin | 2.2% | -2.9% | 1.6% | 6.6% | 12.7% | 16.2% |
USD billions · SEC XBRL
Bioventus Inc. — questions
- What is Bioventus Inc.'s gross margin?
- 68.7% over the twelve months to 2026-06-30.
- What is Bioventus Inc.'s operating margin?
- 10.0% over the twelve months to 2026-06-30.
- What is Bioventus Inc.'s net profit margin?
- 9.4% over the twelve months to 2026-06-30.
Every figure on this page comes from Bioventus Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.